WW Slashes Debt to $465M, Med+ Subscribers Surge 56%
WW sits 92% above its 52-week low of $8.365.
Summary
WW International cut debt from ~$1.6B to ~$465M and expects to be free-cash-flow positive in 2026. Core+ subscribers rose for a third straight quarter, and Med+ telehealth added ~56% more clinical subscribers in Q2 2026, with Med+ expected to contribute 25-30% of 2026 revenue. The company also front-loaded marketing spend to 40-45% of annual budget to boost GLP-1 awareness, which stands at ~30%. This follows the appointment of Stephen Bye as permanent CEO on September 9, 2026, and a Q1 2026 report showing a 22.6% drop in total subscribers. The debt reduction and subscriber growth in higher-value segments mark a notable improvement in the company's financial trajectory.
At the time of this announcement, WW was trading at $16.10 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $161M. The 52-week trading range was $8.37 to $38.38. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.